ASCO in ActionASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.

To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.

Tune in to ASCO's new ASCO in Action podcast series, providing analysis and commentary on cancer policy and practice issues, available through iTunes or Google Play.

Showing results for Federal Funding

May 18, 2018

On May 17, the Senate Appropriations Committee held a hearing to discuss the budget request for the National Institutes of Health (NIH) for Fiscal Year (FY) 2019. NIH Director Francis Collins, MD, PhD, and National Cancer Institute (NCI) Director Ned Sharpless, MD, both gave testimony at the hearing, where Dr. Sharpless underscored the need for adequate funding to strengthen the cancer research infrastructure.

May 10, 2018

On May 8, the White House submitted a rescission package to Congress, which proposes $15 billion in cuts to 38 government programs and agencies, including to the Center for Medicare and Medicaid Innovation.

April 27, 2018

ASCO’s Policy Issue Briefs provide succinct overviews and relevant data on major policy issues impacting patients with cancer and the physicians who care for them. These briefs are designed to be especially helpful for journalists, offering background information on key issues across health policy today.

April 16, 2018

Members of ASCO's Leadership Development Program held a Hill Day to advocate for federal research funding, oral parity, step therapy, and other cancer policy priorities.

April 16, 2018

ASCO submitted a budget request to a House Committee on Appropriations subcommittee, asking for $3.32 billion in funding for the Food and Drug Administration (FDA) and support for the Administration’s request of $20 million for FDA’s Oncology Center of Excellence (OCE) in Fiscal Year (FY) 2019.

March 23, 2018

The American Society of Clinical Oncology (ASCO) applauds Congress for its bipartisan support of the omnibus spending bill that significantly boosts our nation's investment in biomedical research. By providing a $3 billion funding increase for the National Institutes of Health (NIH) for fiscal year (FY) 2018—the biggest NIH funding increase in 15 years—Congress has taken bold action to regain much-needed momentum in cancer research following a decade of stagnant funding for the NIH

March 13, 2018

ASCO's new social media tolkit helps members raise awareness of the National Cancer Institute's important role in advancing cancer research.

February 15, 2018

On February 12, the White House released its Fiscal Year (FY) 2019 budget proposal, which included several provisions and budget changes of interest to the cancer community. While the proposal is not binding, it does provide a view into some of the Administration’s goals and budget priorities for the year. 

February 12, 2018

Robin Zon, MD, FACP, FASCO, a medical oncologist at Michiana Hematology Oncology and last year’s ASCO Advocate of the Year, joined ASCO CEO Dr. Clifford Hudis this month to discuss Congressional advocacy and the role it plays in shaping cancer-related policies.

February 12, 2018

Congress passed the “Bipartisan Budget Act of 2018,” which funds the federal government through March 23, 2018, raises the federal budget caps for the next two years, and addresses several policies of importance to the cancer community.

February 7, 2018

ASCO applauds a provision in the continuing resolution (CR) passed by the House of Representatives yesterday that will ensure that payment adjustments under the Merit-based Incentive Payment System (MIPS) are not applied to Medicare Part B drug reimbursement. ASCO has strongly advocated for this change since the release of a proposed Quality Payment Program rule by the Centers for Medicare and Medicaid Services in June of 2017

January 23, 2018

On January 22, the U.S. Senate and U.S. House of Representatives voted to pass a short-term Continuing Resolution (CR) to keep the federal government funded through February 8, 2018. The CR, which President Trump signed into law, ends a three-day federal government shutdown and keeps funding levels flat for federal agencies, including the National Institutes of Health (NIH) and the National Cancer Institute (NCI).